The University of Kansas Heartland Institute for Clinical and Translational Research (HICTR) was established in 2007 in response to the national CTSA Initiative. The vision of the HICTR is to Improve the health of Kansans by creating a novel and transformative translational research enterprise from bench to bedside to community. Particular strengths of our HICTR program are an entrepreneurial drug and device discovery and development program and a well-developed and highly accomplished community-based research program.
The specific aims of the HICTR are to: 1) create a new academic home with innovative training programs for clinical and translational investigators;2j provide an enhanced coordinated translational research infrastructure;and 3) actively engage the community in developing, testing, and disseminating research, by capitalizing on and expanding existing networks, to improve the health of all Kansans?especially those in rural, underserved and other target communities. The proposed Infrastructure and educational programs of the HICTR will address the challenges facing clinical and translational investigators by enhancing and integrating existing resources for easier access, developing new innovative resources, and capitalizing on resources residing in research centers across the university?including our KINBRE and five COBRE grants~and our HICTR network institutions. In support of our aims, we have marshaled an impressive array of institutional, corporate, and community resources in planning, developing, and establishing the HICTR. The HICTR will provide new infrastructure and training and educational programs to support investigators'clinical and translational research?taking laboratory discoveries to first trials in humans (T1 research) and moving research through to studies on dissemination and implementation of research findings to practice (T2 research). With extraordinary institutional and community support, we already have made tremendous progress. Funding from the CTSA program will allow the University of Kansas'HICTR the opportunity to fully realize its potential not only for our region, but also to contribufe to the national CTSA Consortium.

Public Health Relevance

The University of Kansas Heartland Institute for Clinical and Translational Research is an academic home for clinical and translational research, providing support to scientists and involving the community, so that discoveries and research findings wi|l be brought more rapidly to the point of care, thus improving the health of all Kansans.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Mentored Career Development Award (KL2)
Project #
5KL2TR000119-04
Application #
8638995
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Program Officer
Merchant, Carol
Project Start
2011-06-01
Project End
2016-02-29
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
4
Fiscal Year
2014
Total Cost
$591,909
Indirect Cost
$43,845
Name
University of Kansas
Department
Neurology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Vivian, Carolyn J; Brinker, Amanda E; Graw, Stefan et al. (2017) Mitochondrial Genomic Backgrounds Affect Nuclear DNA Methylation and Gene Expression. Cancer Res 77:6202-6214
Ellis, Kelstan Lynch; Randell, Kimberly; Lantos, John et al. (2017) Trust in the Medical Profession Among Adolescents in an Emergency Department. Pediatr Emerg Care :
Koestler, Devin C; Usset, Joseph; Christensen, Brock C et al. (2017) DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes. Cancer Epidemiol Biomarkers Prev 26:328-338
Winterbottom, Emily F; Koestler, Devin C; Fei, Dennis Liang et al. (2017) The aquaglyceroporin AQP9 contributes to the sex-specific effects of in utero arsenic exposure on placental gene expression. Environ Health 16:59
Pessetto, Ziyan Y; Chen, Bin; Alturkmani, Hani et al. (2017) In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma. Oncotarget 8:4079-4095
Taylor, Jacob M; Hamilton-Reeves, Jill M; Sullivan, Debra K et al. (2017) Diet and polycystic kidney disease: A pilot intervention study. Clin Nutr 36:458-466
El-Gohary, Mahmoud; Peterson, Daniel; Gera, Geetanjali et al. (2017) Validity of the Instrumented Push and Release Test to Quantify Postural Responses in Persons With Multiple Sclerosis. Arch Phys Med Rehabil 98:1325-1331
Upadhyayula, Satyasree; Ramaswamy, Megha; Chalise, Prabhakar et al. (2017) The Association of Ethnic Pride With Health and Social Outcomes Among Young Black and Latino Men After Release From Jail. Youth Soc 49:1057-1076
Salas, Lucas A; Johnson, Kevin C; Koestler, Devin C et al. (2017) Integrative epigenetic and genetic pan-cancer somatic alteration portraits. Epigenetics 12:561-574
Billinger, Sandra A; Vidoni, Eric D; Morris, Jill K et al. (2017) Exercise Test Performance Reveals Evidence of the Cardiorespiratory Fitness Hypothesis. J Aging Phys Act 25:240-246

Showing the most recent 10 out of 93 publications